Table 2.
Biochemical parameters of the patients enrolled in this study.
| Parameter | Survivor (n=46) | Nonsurvivor (n=26) | P |
|---|---|---|---|
| ALT∗ (U/L) | 224 (127–465) | 239 (108–405) | 0.862 |
| γ-GT∗ (U/L) | 70 (35–227) | 70 (30–279) | 0.872 |
| TBIL∗ (μmol/L) | 13 (7–46) | 73 (21–130) | 0.001 |
| ALB (g/L) | 32 (29–37) | 29 (26–33) | 0.152 |
| PT∗ (s) | 13.9 (12.0–16.1) | 15.4 (13.0–19.1) | 0.023 |
| APTT∗ (s) | 36.4 (29.9–42.1) | 44.0 (34.9–58.0) | 0.002 |
| TBA∗ (μmol/L) | 20 (8–54) | 47 (32–96) | 0.021 |
| INR∗ | 1.20 (1.03–1.41) | 1.28 (1.11–1.55) | 0.104 |
ALT: alanine transaminase; γ-GT: γ-glutamyltransferase; TBIL: total bilirubin; ALB: albumin; PT: prothrombin time; APTT: activated partial thromboplastin time; INR: international normalized ratio; TBA: total bile acid. Data are presented as median (IQR). ∗Indicated that data were treated with Ln processing.